| Date | Form | Description | Docs | XBRL | Pages |
| 09/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/16/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/12/19 | DEF 14A | Definitive proxy statements |
|
46 | |
| 09/06/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
84 |
| 08/27/19 | 8-K | Current report filing |
|
13 | |
| 08/21/19 | 8-K | Current report filing |
|
25 | |
| 07/18/19 | 8-K | Current report filing |
|
4 | |
| 06/21/19 | EFFECT | Notice of Effectiveness |
|
1 | |
| 06/19/19 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 06/18/19 | UPLOAD | SEC-generated letter |
|
1 |
Latest News & Events
Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic
Read More...Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million
Read More...Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock
Read More...